Bethyl Laboratories
Rabbit anti-RBM34 IHC Antibody Affinity Purified
Primary
Catalog #IHC-00661
TargetRBM34
HostRabbit
ClonalityPolyclonal
ReactivityHuman
ApplicationIHC
Image 1 of 1
local_shipping
Order within 17 hours and 57 minutes for shipment by Tuesday, November 10
Product Description
RNA binding motif protein 34 (RBM34) is an RRM (RNA recognition motif)-containing protein.
Specifications
Clonality
Polyclonal
Host
Rabbit
Immunogen
Between 380 and C-terminus
Isotype
IgG
Reactivity
Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Antigen Affinity Purified
Concentration
250 µg/ml
Target Identity
TargetRBM34
Antigen Species
Human
Gene ID23029
Gene Symbol
RBM34
Gene Name
RNA binding motif protein 34
Uniprot IDP42696
Protein Name
RNA-binding protein 34
Product Information
Applications
IHC
Buffer
Tris-buffered Saline containing 0.1% BSA and 0.09% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Production & Epitope
Antibody was affinity purified using an epitope specific to RBM34 immobilized on solid support.
The epitope recognized by IHC-00661 maps to a region between residue 370 and 430 of human RNA binding motif protein 34 using the numbering given in entry CAI21936.1 (GeneID 23029).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Applications
Epitope exposure is recommended.
Epitope exposure with citrate buffer will enhance staining.
Likely to work with frozen sections.
In some cases, the antibody may be diluted further than indicated.
Immunohistochemistry (IHC)1:100 - 1:500
Documents
Safety Data SheetPDF · IHC-00661Open
Product DatasheetPDF · IHC-00661 · Lot 1 (current lot)Open
Product DatasheetPDF · IHC-00661 · Lot 1 (current lot)Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1